Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $255.16 million. The enterprise value is $69.04 million.
Important Dates
The last earnings date was Wednesday, August 13, 2025, after market close.
Earnings Date | Aug 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ALLO has 221.88 million shares outstanding. The number of shares has increased by 22.85% in one year.
Current Share Class | 221.88M |
Shares Outstanding | 221.88M |
Shares Change (YoY) | +22.85% |
Shares Change (QoQ) | +1.66% |
Owned by Insiders (%) | 6.76% |
Owned by Institutions (%) | 66.79% |
Float | 164.98M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.73 |
P/TBV Ratio | 0.74 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.92, with a Debt / Equity ratio of 0.25.
Current Ratio | 8.92 |
Quick Ratio | 8.68 |
Debt / Equity | 0.25 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -402.61 |
Financial Efficiency
Return on equity (ROE) is -55.12% and return on invested capital (ROIC) is -28.96%.
Return on Equity (ROE) | -55.12% |
Return on Assets (ROA) | -26.98% |
Return on Invested Capital (ROIC) | -28.96% |
Return on Capital Employed (ROCE) | -54.95% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.03M |
Employee Count | 229 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ALLO has paid $443,000 in taxes.
Income Tax | 443,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.43% in the last 52 weeks. The beta is 0.36, so ALLO's price volatility has been lower than the market average.
Beta (5Y) | 0.36 |
52-Week Price Change | -55.43% |
50-Day Moving Average | 1.20 |
200-Day Moving Average | 1.59 |
Relative Strength Index (RSI) | 50.12 |
Average Volume (20 Days) | 3,967,535 |
Short Selling Information
The latest short interest is 24.47 million, so 11.03% of the outstanding shares have been sold short.
Short Interest | 24.47M |
Short Previous Month | 24.45M |
Short % of Shares Out | 11.03% |
Short % of Float | 14.83% |
Short Ratio (days to cover) | 4.64 |
Income Statement
Revenue | n/a |
Gross Profit | -180.04M |
Operating Income | -241.16M |
Pretax Income | -251.88M |
Net Income | -236.91M |
EBITDA | -228.52M |
EBIT | -241.16M |
Earnings Per Share (EPS) | -$1.11 |
Full Income Statement Balance Sheet
The company has $273.12 million in cash and $87.00 million in debt, giving a net cash position of $186.12 million or $0.84 per share.
Cash & Cash Equivalents | 273.12M |
Total Debt | 87.00M |
Net Cash | 186.12M |
Net Cash Per Share | $0.84 |
Equity (Book Value) | 344.56M |
Book Value Per Share | 1.57 |
Working Capital | 250.98M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$172.77 million and capital expenditures -$829,000, giving a free cash flow of -$173.60 million.
Operating Cash Flow | -172.77M |
Capital Expenditures | -829,000 |
Free Cash Flow | -173.60M |
FCF Per Share | -$0.78 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.85% |
Shareholder Yield | -22.85% |
Earnings Yield | -92.85% |
FCF Yield | -68.04% |
Analyst Forecast
The average price target for ALLO is $8.88, which is 672.17% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.88 |
Price Target Difference | 672.17% |
Analyst Consensus | Strong Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 606.43% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ALLO has an Altman Z-Score of -4.69 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.69 |
Piotroski F-Score | 1 |